Cervical cancer awareness month: advances in prevention and treatment скачать в хорошем качестве

Cervical cancer awareness month: advances in prevention and treatment

In recognition of Cervical Cancer Awareness Month, this episode of VJOncology podcasts explores advances in cervical cancer prevention and treatment. We hear from three leading experts who discuss pivotal developments shaping clinical practice. Dr Domenica Lorusso from Fondazione IRCCS National Cancer Institute of Milan examines the breakthrough combination of immunotherapy and radiotherapy in locally advanced disease, highlighting practice-changing data from the KEYNOTE-A18 trial that established pembrolizumab plus chemoradiotherapy as the new standard of care for stage 3 cervical cancer. Dr Amanda Psyrri from National Kapodistrian University of Athens underscores the critical role of HPV vaccination in preventing not only cervical cancer but also HPV-associated oropharyngeal malignancies, particularly those caused by high-risk subtypes 16 and 18. Finally, Dr Alberto Farolfi from IRCCS Istituto Romagnolo per lo Studio dei Tumori shares real-world evidence on the addition of bevacizumab to pembrolizumab-chemotherapy regimens in advanced cervical cancer, demonstrating survival benefits without increased serious adverse events. This episode offers essential insights into the evolving landscape of cervical cancer management from prevention through advanced disease.